Animal Models & Clinical Trials

The development of human vaccines continues to rely on the use of animals for research. Regulatory authorities require novel vaccine candidates to undergo preclinical assessment in animal models before being permitted to enter the clinical phase in human subjects. Substantial progress has been made in recent years in reducing and replacing the number of animals used for preclinical vaccine research through the use of bioinformatics and computational biology to design new vaccine candidates. However, the ultimate goal of a new vaccine is to instruct the immune system to elicit an effective immune response against the pathogen of interest, and no alternatives to live animal use currently exist for evaluation of this response.

    Related Conference of Animal Models & Clinical Trials

    November 19-20, 2025

    6th International Conference on Vaccine Research

    Tokyo, Japan
    December 22-23, 2025

    7th World Congress on Vaccine and Immunology

    Amsterdam, Netherlands
    September 21-22, 2026

    44th Euro Global Summit and Expo on Vaccines & Vaccination

    Barcelona, Spain

    Animal Models & Clinical Trials Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in